| Opinion Article: Res Rev Drug Deliv |
| Personalized Cancer Immunotherapies: New Frontiers in Targeted Drug Delivery |
| Jordan Daves* |
| Perspective Article: Res Rev Drug Deliv |
| Drug Regulation and Approval: Impact of Accelerated Processes in the COVID Era |
| Duncan Elledge* |
| Commentary: Res Rev Drug Deliv |
| The Potential of Cell-Based Therapies in Drug Development |
| Ursala Fischer* |
| Short Communication: Res Rev Drug Deliv |
| Metabolism of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Their Side Effects |
| Kattab Omar |
| Commentary: Res Rev Drug Deliv |
| Nanoparticles in Drug Delivery for Cancer Immunotherapy |
| Patrick Leonard |
Menu
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi